Polachini, C.R., Spanevello, R.M., Zanini, D., Baldissarelli, J., Pereira, L.B., Schetinger, M.R., da Cruz, I.B., Assmann, C.E., Bagatini, M.D. and Morsch, V.M. (2016) Evaluation of Delta Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis. Neurotoxicity Research, 29, 230-242.
https://doi.org/10.1007/s12640-015-9584-2

has been cited by the following article:

• TITLE: Serum Level of Vitamin C in a Sample of Egyptian Patients with Multiple Sclerosis

  AUTHORS: Asmaa Ibrahim, Taha K. Alloush, Yousry Abo Elnaga, Mohamed Hamdy, Mohamed M. Fouad

  KEYWORDS: Vitamin C, Multiple Sclerosis

  JOURNAL NAME: Neuroscience and Medicine, Vol.10 No.4, December 27, 2019

  ABSTRACT: Background: Antioxidants such as vitamin C can eliminate free radicles responsible for oxidative stress. Objective: To assess the serum level of vitamin C in a sample of multiple sclerosis (MS) patients to investigate a possible role of vitamin C in the pathogenesis of MS. Subjects and Methods: Forty patients with MS and twenty healthy controls were included in this study. Vitamin C level was estimated for each participant. Results: Serum vitamin C levels were significantly lower among the patients (ranging from 0.28 mg/dL to 0.75 mg/dL with mean 0.47 ± 0.14 mg/dL and median of 0.46 mg/dL) compared to controls (ranging from 0.60 mg/dL to 2.90 mg/dL with mean 1.87 ± 0.61 mg/dL and median of 1.90 mg/dL) (P Conclusion: Patients with MS tended to have low serum vitamin C levels, and younger patients had lower serum levels.